Brainstem tau pathology in Alzheimer’s disease is characterized by increase of three repeat tau and independent of amyloid β

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 2051-5960

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Brainstem tau pathology in Alzheimer’s disease is characterized by increase of three repeat tau and independent of amyloid β ; volume:6 ; number:1 ; day:3 ; month:1 ; year:2018 ; pages:1-18 ; date:12.2018
Acta Neuropathologica Communications ; 6, Heft 1 (3.1.2018), 1-18, 12.2018

Keyword: Hirnkrankheit
Neuropsychiatrie
Nervenkrankheit

Creator: Uematsu, Miho

Contributor: Nakamura, Ayako
Ebashi, Momoko
Hirokawa, Katsuiku
Takahashi, Ryosuke
Uchihara, Toshiki
SpringerLink (Online service)

DOI: 10.1186/s40478-017-0501-1

URN: urn:nbn:de:1111-201802274732

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:47 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Uematsu, Miho
Nakamura, Ayako
Ebashi, Momoko
Hirokawa, Katsuiku
Takahashi, Ryosuke
Uchihara, Toshiki
SpringerLink (Online service)

Other Objects (12)

Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease

Human tau-overexpressing mice recapitulate brainstem involvement and neuropsychiatric features of early Alzheimer’s disease

Plasma N-terminal containing tau fragments (NTA-tau): a biomarker of tau deposition in Alzheimer’s Disease

Tau-focused therapy and tau transmission: Implications for Alzheimer’s Disease and related tauopathies

Principal components of tau positron emission tomography and longitudinal tau accumulation in Alzheimer’s disease

Detection of Alzheimer’s disease (AD) specific tau pathology with conformation-selective anti-tau monoclonal antibody in co-morbid frontotemporal lobar degeneration-tau (FTLD-tau)

Critical residues involved in tau binding to fyn: implications for tau phosphorylation in Alzheimer’s disease

Brain vasculature accumulates tau and is spatially related to tau tangle pathology in Alzheimer’s disease

Propagation of Tau pathology in Alzheimer disease

APOE effects on regional tau in preclinical Alzheimer’s disease

First-in-man tau vaccine targeting structural determinants essential for pathological tau–tau interaction reduces tau oligomerisation and neurofibrillary degeneration in an Alzheimer’s disease model

Longitudinal tau and metabolic PET imaging in relation to novel CSF tau measures in Alzheimer’s disease

Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease

Human tau-overexpressing mice recapitulate brainstem involvement and neuropsychiatric features of early Alzheimer’s disease

Plasma N-terminal containing tau fragments (NTA-tau): a biomarker of tau deposition in Alzheimer’s Disease

Tau-focused therapy and tau transmission: Implications for Alzheimer’s Disease and related tauopathies

Principal components of tau positron emission tomography and longitudinal tau accumulation in Alzheimer’s disease

Detection of Alzheimer’s disease (AD) specific tau pathology with conformation-selective anti-tau monoclonal antibody in co-morbid frontotemporal lobar degeneration-tau (FTLD-tau)

Critical residues involved in tau binding to fyn: implications for tau phosphorylation in Alzheimer’s disease

Brain vasculature accumulates tau and is spatially related to tau tangle pathology in Alzheimer’s disease

Propagation of Tau pathology in Alzheimer disease

APOE effects on regional tau in preclinical Alzheimer’s disease

First-in-man tau vaccine targeting structural determinants essential for pathological tau–tau interaction reduces tau oligomerisation and neurofibrillary degeneration in an Alzheimer’s disease model

Longitudinal tau and metabolic PET imaging in relation to novel CSF tau measures in Alzheimer’s disease

Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease

Human tau-overexpressing mice recapitulate brainstem involvement and neuropsychiatric features of early Alzheimer’s disease

Plasma N-terminal containing tau fragments (NTA-tau): a biomarker of tau deposition in Alzheimer’s Disease

Tau-focused therapy and tau transmission: Implications for Alzheimer’s Disease and related tauopathies

Principal components of tau positron emission tomography and longitudinal tau accumulation in Alzheimer’s disease

Detection of Alzheimer’s disease (AD) specific tau pathology with conformation-selective anti-tau monoclonal antibody in co-morbid frontotemporal lobar degeneration-tau (FTLD-tau)

Critical residues involved in tau binding to fyn: implications for tau phosphorylation in Alzheimer’s disease

Brain vasculature accumulates tau and is spatially related to tau tangle pathology in Alzheimer’s disease

Propagation of Tau pathology in Alzheimer disease

APOE effects on regional tau in preclinical Alzheimer’s disease

First-in-man tau vaccine targeting structural determinants essential for pathological tau–tau interaction reduces tau oligomerisation and neurofibrillary degeneration in an Alzheimer’s disease model

Longitudinal tau and metabolic PET imaging in relation to novel CSF tau measures in Alzheimer’s disease

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Brainstem tau pathology in Alzheimer’s disease is characterized by increase of three repeat tau and independent of amyloid β

Object Details

References and Relationships

Classification and Topics

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease

Human tau-overexpressing mice recapitulate brainstem involvement and neuropsychiatric features of early Alzheimer’s disease

Plasma N-terminal containing tau fragments (NTA-tau): a biomarker of tau deposition in Alzheimer’s Disease

Tau-focused therapy and tau transmission: Implications for Alzheimer’s Disease and related tauopathies

Principal components of tau positron emission tomography and longitudinal tau accumulation in Alzheimer’s disease

Detection of Alzheimer’s disease (AD) specific tau pathology with conformation-selective anti-tau monoclonal antibody in co-morbid frontotemporal lobar degeneration-tau (FTLD-tau)

Critical residues involved in tau binding to fyn: implications for tau phosphorylation in Alzheimer’s disease

Brain vasculature accumulates tau and is spatially related to tau tangle pathology in Alzheimer’s disease

Propagation of Tau pathology in Alzheimer disease

APOE effects on regional tau in preclinical Alzheimer’s disease

First-in-man tau vaccine targeting structural determinants essential for pathological tau–tau interaction reduces tau oligomerisation and neurofibrillary degeneration in an Alzheimer’s disease model

Longitudinal tau and metabolic PET imaging in relation to novel CSF tau measures in Alzheimer’s disease

Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease

Human tau-overexpressing mice recapitulate brainstem involvement and neuropsychiatric features of early Alzheimer’s disease

Plasma N-terminal containing tau fragments (NTA-tau): a biomarker of tau deposition in Alzheimer’s Disease

Tau-focused therapy and tau transmission: Implications for Alzheimer’s Disease and related tauopathies

Principal components of tau positron emission tomography and longitudinal tau accumulation in Alzheimer’s disease

Detection of Alzheimer’s disease (AD) specific tau pathology with conformation-selective anti-tau monoclonal antibody in co-morbid frontotemporal lobar degeneration-tau (FTLD-tau)

Critical residues involved in tau binding to fyn: implications for tau phosphorylation in Alzheimer’s disease

Brain vasculature accumulates tau and is spatially related to tau tangle pathology in Alzheimer’s disease

Propagation of Tau pathology in Alzheimer disease

APOE effects on regional tau in preclinical Alzheimer’s disease

First-in-man tau vaccine targeting structural determinants essential for pathological tau–tau interaction reduces tau oligomerisation and neurofibrillary degeneration in an Alzheimer’s disease model

Longitudinal tau and metabolic PET imaging in relation to novel CSF tau measures in Alzheimer’s disease

Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease

Human tau-overexpressing mice recapitulate brainstem involvement and neuropsychiatric features of early Alzheimer’s disease

Plasma N-terminal containing tau fragments (NTA-tau): a biomarker of tau deposition in Alzheimer’s Disease

Tau-focused therapy and tau transmission: Implications for Alzheimer’s Disease and related tauopathies

Principal components of tau positron emission tomography and longitudinal tau accumulation in Alzheimer’s disease

Detection of Alzheimer’s disease (AD) specific tau pathology with conformation-selective anti-tau monoclonal antibody in co-morbid frontotemporal lobar degeneration-tau (FTLD-tau)

Critical residues involved in tau binding to fyn: implications for tau phosphorylation in Alzheimer’s disease

Brain vasculature accumulates tau and is spatially related to tau tangle pathology in Alzheimer’s disease

Propagation of Tau pathology in Alzheimer disease

APOE effects on regional tau in preclinical Alzheimer’s disease

First-in-man tau vaccine targeting structural determinants essential for pathological tau–tau interaction reduces tau oligomerisation and neurofibrillary degeneration in an Alzheimer’s disease model

Longitudinal tau and metabolic PET imaging in relation to novel CSF tau measures in Alzheimer’s disease

Related objects

Reset password